1. Home
  2. RNTX vs PFAI Comparison

RNTX vs PFAI Comparison

Compare RNTX & PFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

PFAI

Pinnacle Food Group Limited

N/A

Current Price

$3.80

Market Cap

46.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
RNTX
PFAI
Founded
2001
2015
Country
United States
Canada
Employees
10
13
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
46.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
PFAI
Price
$1.02
$3.80
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
841.5K
2.1K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$1.30
52 Week High
$2.18
$4.93

Technical Indicators

Market Signals
Indicator
RNTX
PFAI
Relative Strength Index (RSI) 39.26 54.19
Support Level N/A $3.53
Resistance Level $1.33 $4.09
Average True Range (ATR) 0.08 0.15
MACD 0.01 -0.03
Stochastic Oscillator 24.94 56.15

Price Performance

Historical Comparison
RNTX
PFAI

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About PFAI Pinnacle Food Group Limited

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

Share on Social Networks: